These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2430072)

  • 1. Treatment of non-small-cell lung cancer.
    Mulshine JL; Glatstein E; Ruckdeschel JC
    J Clin Oncol; 1986 Nov; 4(11):1704-15. PubMed ID: 2430072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.
    Toschi L; Cappuzzo F; Jänne PA
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix150-5. PubMed ID: 17631569
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?
    Wozniak AJ; Gadgeel SM
    Oncology (Williston Park); 2007 Feb; 21(2):163-71; discussion 171, 174, 179-82. PubMed ID: 17396481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role for epidermal growth factor receptor inhibitors in combined-modality therapy for non-small-cell lung cancer.
    Kim DW; Choy H
    Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):11-20. PubMed ID: 15142630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
    García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
    Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer.
    Coate LE; Massey C; Hope A; Sacher A; Barrett K; Pierre A; Leighl N; Brade A; de Perrot M; Waddell T; Liu G; Feld R; Burkes R; Cho BC; Darling G; Sun A; Keshavjee S; Bezjak A; Shepherd FA
    J Thorac Oncol; 2011 Mar; 6(3):537-44. PubMed ID: 21258243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant immunotherapy for non-small cell lung cancer.
    Tucker ZC; Laguna BA; Moon E; Singhal S
    Cancer Treat Rev; 2012 Oct; 38(6):650-61. PubMed ID: 22226940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage IIIB non-small-cell lung cancer.
    Rendina EA; Venuta F; De Giacomo T; Furio Coloni G
    Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors.
    Santarpia M; Altavilla G; Pitini V; Rosell R
    Future Oncol; 2015; 11(8):1259-74. PubMed ID: 25832881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of localized non-small cell lung cancer (take home messages).
    Baumann M; Stamatis G; Thomas M
    Lung Cancer; 2001 Sep; 33 Suppl 1():S47-9. PubMed ID: 11576707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy.
    Bebb G; Smith C; Rorke S; Boland W; Nicacio L; Sukhoo R; Brade A
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):837-45. PubMed ID: 20563810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment paradigms for locally advanced non-small cell lung cancer.
    Rigas JR; Kelly K
    J Thorac Oncol; 2007 Jun; 2 Suppl 2():S77-85. PubMed ID: 17589303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Moro D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
    [No Abstract]   [Full Text] [Related]  

  • 19. ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.
    Rosenzweig KE; Movsas B; Bradley J; Gewanter RM; Gopal RS; Komaki RU; Kong FM; Lee HK; Feins RH; Langer CJ
    J Am Coll Radiol; 2009 Feb; 6(2):85-95. PubMed ID: 19179235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.